Will Ashworth

Will Ashworth

InvestorPlace Contributor

Expertise: Public and private companies, Portfolio construction

About Will:
Will Ashworth has written about investments full-time since 2008. He loves investing and is passionate about helping others put their money to work. He particularly enjoys creating model portfolios that stand the test of time.

Publications where he’s appeared include InvestorPlace, The Motley Fool Canada, Investopedia, Kiplinger, and several others in both the U.S. and Canada. He lives in Halifax, Nova Scotia.

You can follow Will on LinkedIn. 

Recent Articles

Will Increased Competition in China Affect Starbucks Stock?

By Will Ashworth, InvestorPlace Contributor

Chinese coffee startup Luckin Coffee is looking to steal SBUX's thunder in China. Should owners of Starbucks stock be worried?.

The Case Against Pfizer Stock and the Rest of the Industry

By Will Ashworth, InvestorPlace Contributor

A recent article in the investment media asked if Pfizer stock was a better buy than Eli Lilly stock. Here’s why I wouldn’t buy either.

After a Brutal Year, the Dog Days Are over for Activision Stock

By Will Ashworth, InvestorPlace Contributor

Never easy, CEO Bobby Kotick announced that 8% of its staff or 750 people would lose their jobs. The restructuring would see the money saved from 750 paychecks reinvested in its core and incubation development teams. In 2019, it plans to increase spending by 20% in this vital area of its business.

7 ETFs to Buy to Ride the Longevity Economy

By Will Ashworth, InvestorPlace Contributor

As people live longer, the longevity economy will continue to grow. These seven ETFs to buy give investors the edge.

Target Continues to Hit the Bullseye

By Will Ashworth, InvestorPlace Contributor

Target (NYSE:TGT) is running on all cylinders right now, making Target stock a very attractive investment option. 

7 Stocks to Buy With High ESG Momentum

By Will Ashworth, InvestorPlace Contributor

If you’re looking for stocks to buy you might want to give companies with improving environmental, social and governance (ESG) ratings a try.

Why Tesla’s Shift to an Online Sales Model Is Positive for Tesla Stock

By Will Ashworth, InvestorPlace Contributor

TSLA is closing its stores to save money; money that it can use to lower the actual price of its vehicles. The move will boost TSLA stock.

Eli Lilly’s Latest Move Proves the American Healthcare System Is Broken

By Will Ashworth, InvestorPlace Contributor

In 2018, Humalog generated $3.0 billion for Eli Lilly, 5% higher than a year earlier. Assuming Humalog’s gross margin is 73.8% (I’m using the company’s overall gross margin; it’s likely higher), Eli Lilly had $2.2 billion in gross profits from this single drug. Except for Trulicity, the company’s bestselling diabetes drug, Humalog is the company’s second-largest revenue and profit generator.

Should Big Tech Be Broken Up?

By Will Ashworth, InvestorPlace Contributor

Senator Elizabeth Warren believes that the big tech stocks ought to be broken up. Whether it does indeed happen, it shouldn't be feared.

Boeing Stock: Should Investors Buy On Weakness In Wake Of Ethiopia Crash?

By Will Ashworth, InvestorPlace Contributor

Don't mistake the terrible things that happen with a crappy company or stock. Boeing’s neither of those despite the current optics.

Load More